FI20115631A0 - Immunostimulatoriska föreningar och användningar därav - Google Patents

Immunostimulatoriska föreningar och användningar därav

Info

Publication number
FI20115631A0
FI20115631A0 FI20115631A FI20115631A FI20115631A0 FI 20115631 A0 FI20115631 A0 FI 20115631A0 FI 20115631 A FI20115631 A FI 20115631A FI 20115631 A FI20115631 A FI 20115631A FI 20115631 A0 FI20115631 A0 FI 20115631A0
Authority
FI
Finland
Prior art keywords
immunostimulatory compounds
immunostimulatory
compounds
Prior art date
Application number
FI20115631A
Other languages
English (en)
Finnish (fi)
Inventor
Johannes Savolainen
Kaarina Ranta
Reko Leino
Chinmoy Mukherjee
Original Assignee
Turun Yliopisto
Aabo Akademi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Turun Yliopisto, Aabo Akademi University filed Critical Turun Yliopisto
Priority to FI20115631A priority Critical patent/FI20115631A0/sv
Publication of FI20115631A0 publication Critical patent/FI20115631A0/sv
Priority to KR1020147001662A priority patent/KR20140108209A/ko
Priority to EP12745500.4A priority patent/EP2723754B1/en
Priority to US14/128,464 priority patent/US9221861B2/en
Priority to CA2842136A priority patent/CA2842136C/en
Priority to PT127455004T priority patent/PT2723754T/pt
Priority to PCT/FI2012/050650 priority patent/WO2012175813A1/en
Priority to AU2012273838A priority patent/AU2012273838B2/en
Priority to CN201280040770.8A priority patent/CN103814041B/zh
Priority to ES12745500.4T priority patent/ES2629052T3/es
Priority to DK12745500.4T priority patent/DK2723754T3/en
Priority to JP2014516407A priority patent/JP6073306B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI20115631A 2011-06-21 2011-06-21 Immunostimulatoriska föreningar och användningar därav FI20115631A0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FI20115631A FI20115631A0 (sv) 2011-06-21 2011-06-21 Immunostimulatoriska föreningar och användningar därav
JP2014516407A JP6073306B2 (ja) 2011-06-21 2012-06-21 免疫賦活化合物としての多価［β］−１，２−結合マンノースオリゴ糖及びその使用
CA2842136A CA2842136C (en) 2011-06-21 2012-06-21 Multivalent [beta]-1-2-linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
EP12745500.4A EP2723754B1 (en) 2011-06-21 2012-06-21 Multivalent [beta]-1-2-linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
US14/128,464 US9221861B2 (en) 2011-06-21 2012-06-21 Multivalent [beta]-1-2-linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
KR1020147001662A KR20140108209A (ko) 2011-06-21 2012-06-21 다가 베타-1,2-연결된 만노스 올리고당 면역자극 화합물 및 이의 용도
PT127455004T PT2723754T (pt) 2011-06-21 2012-06-21 Oligossacáridos de manose multivalentes ligados por [beta]-1,2 como compostos imunoestimuladores e as suas utilizações
PCT/FI2012/050650 WO2012175813A1 (en) 2011-06-21 2012-06-21 Multivalent [beta] - 1 - 2 - linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
AU2012273838A AU2012273838B2 (en) 2011-06-21 2012-06-21 Multivalent (beta) - 1 - 2 - linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
CN201280040770.8A CN103814041B (zh) 2011-06-21 2012-06-21 作为免疫刺激化合物的多价[β]-1-2-连接的甘露寡糖及其用途
ES12745500.4T ES2629052T3 (es) 2011-06-21 2012-06-21 Oligosacáridos de manosa con conexiones [beta]-1-2 multivalentes como compuestos inmunoestimuladores y usos de los mismos
DK12745500.4T DK2723754T3 (en) 2011-06-21 2012-06-21 MULTIVALENT [BETA] -1-2-CONNECTED MANNOSE OLIGOSACCHARIDES AS IMMUNOSTIMULATORY RELATIONS AND APPLICATIONS THEREOF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20115631A FI20115631A0 (sv) 2011-06-21 2011-06-21 Immunostimulatoriska föreningar och användningar därav

Publications (1)

Publication Number Publication Date
FI20115631A0 true FI20115631A0 (sv) 2011-06-21

Family

ID=44206840

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20115631A FI20115631A0 (sv) 2011-06-21 2011-06-21 Immunostimulatoriska föreningar och användningar därav

Country Status (12)

Country Link
US (1) US9221861B2 (sv)
EP (1) EP2723754B1 (sv)
JP (1) JP6073306B2 (sv)
KR (1) KR20140108209A (sv)
CN (1) CN103814041B (sv)
AU (1) AU2012273838B2 (sv)
CA (1) CA2842136C (sv)
DK (1) DK2723754T3 (sv)
ES (1) ES2629052T3 (sv)
FI (1) FI20115631A0 (sv)
PT (1) PT2723754T (sv)
WO (1) WO2012175813A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016378817A1 (en) 2015-12-22 2018-07-19 Turun Yliopisto Immunostimulatory adjuvants and uses thereof
EP3672600A4 (en) * 2017-08-21 2021-05-19 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
CN107712895A (zh) * 2017-10-27 2018-02-23 成都长力元生物科技有限公司 一种预防和治疗花粉过敏症的保健食品及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488929B2 (en) 1994-05-23 2002-12-03 Montana State University Candida albicans phosphomannan complex as a vaccine
CA2417867C (en) 2000-07-31 2012-09-11 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
US7587171B2 (en) 2005-03-09 2009-09-08 Atc Technologies, Llc Reducing interference in a wireless communications signal in the frequency domain
US20080193481A1 (en) * 2005-03-14 2008-08-14 Governors Of The University Of Alberta Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines
WO2007010084A2 (en) 2005-07-15 2007-01-25 Johannes Savolainen Immunostimulatory oligo- and polysaccharides and uses thereof

Also Published As

Publication number Publication date
ES2629052T3 (es) 2017-08-07
US20140105932A1 (en) 2014-04-17
EP2723754B1 (en) 2017-03-22
CN103814041A (zh) 2014-05-21
DK2723754T3 (en) 2017-07-03
US9221861B2 (en) 2015-12-29
KR20140108209A (ko) 2014-09-05
PT2723754T (pt) 2017-06-30
CN103814041B (zh) 2016-09-21
AU2012273838A1 (en) 2014-01-30
WO2012175813A1 (en) 2012-12-27
JP6073306B2 (ja) 2017-02-01
JP2014520136A (ja) 2014-08-21
AU2012273838B2 (en) 2017-07-27
CA2842136C (en) 2019-06-11
CA2842136A1 (en) 2012-12-27
EP2723754A1 (en) 2014-04-30

Similar Documents

Publication Publication Date Title
DK2744810T4 (da) Tenofovir-alafenamid-hemifumarat
DK2769050T3 (da) Propsensor
BR112014000912A2 (pt) ventilador
BR112014000879A2 (pt) deflegmador
DK3272861T3 (da) Alpha-galactosidase-sammensætninger
CO6960543A2 (es) 2-tiopirimidinonas
DE102011100082A8 (de) Traygreifvorrichtung
BR112014005756A2 (pt) vacina
DE102012102142A8 (de) Gebläse
DK3141251T3 (da) Koloskopi - forberedelse
DE112011104936A5 (de) Stanzstauchniet
DK2672817T3 (da) Forbedrede insekticide formuleringer
DE112012000958A5 (de) Handsäge
DK2476953T3 (da) Fluidbedkedel
FI20115631A0 (sv) Immunostimulatoriska föreningar och användningar därav
DE112012002458A5 (de) Hydrotransformator
DE112012000819A5 (de) Gurtbandfänger
DE112012005313A5 (de) Leuchtbild
DK2526750T3 (da) Høbjærgningsmaskine
DE112012001294T8 (de) Umspritzungsverfahren
IT1403657B1 (it) Ventilconvettore
DE112012004426A5 (de) Lüfter
DE102011117169A8 (de) Absetzplattenanordnung
DE112011105396A5 (de) Nachverfestigungsverfahren
FI9398U1 (sv) Flat-LED-armatur och Flat-LED-armaturarrangemang

Legal Events

Date Code Title Description
FD Application lapsed